(Q33195848)

23 July 2017

Defining a serological correlate of protection in rabbits for a recombinant anthrax vaccine (English)

1 reference

23 July 2017

1 reference

Little SF

1

1 reference

23 July 2017

Ivins BE

2

1 reference

23 July 2017

Fellows PF

3

1 reference

23 July 2017

Pitt ML

4

1 reference

23 July 2017

Norris SL

5

1 reference

23 July 2017

Andrews GP

6

1 reference

23 July 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

23 July 2017

1 reference

23 July 2017

22

1 reference

23 July 2017

422-430

1 reference

23 July 2017

3-4

1 reference

Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax

23 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.004

Field Evaluation of a Human Anthrax Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.004

Identification of the cellular receptor for anthrax toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.004

Anthrax toxin protective antigen is activated by a cell surface protease with the sequence specificity and catalytic properties of furin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.004

The pathogenesis of the lethal effect of anthrax toxin in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.004

Purification of factor I and recognition of a third factor of the anthrax toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.004

Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.004

Zinc content of the Bacillus anthracis lethal factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.004

Anthrax toxin lethal factor contains a zinc metalloprotease consensus sequence which is required for lethal toxin activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.004

Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.004

Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.004

Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.004

In vitro correlate of immunity in a rabbit model of inhalational anthrax

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.004

Isolation of an asporogenic (spoOA) protective antigen-producing strain of Bacillus anthracis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.004

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.004

Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.004

Search for correlates of protective immunity conferred by anthrax vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.004

Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.004

Demonstration of a capsule plasmid in Bacillus anthracis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Fermentation, purification, and characterization of protective antigen from a recombinant, avirulent strain of Bacillus anthracis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.07.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2003.07.004

1 reference

23 July 2017

1 reference